CCL5 and cytokine expression in the rat brain: Differential modulation by chronic morphine and morphine withdrawal

Brain, Behavior, and Immunity

Volumn 34, Issue , 2013, Pages 130-140

  Campbell, Lee A ^a   Avdoshina, Valeriya ^a   Rozzi, Summer ^a   Mocchetti, Italo ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CCL5; Frontal cortex; IL 1 ; Microglia; Morphine dependence; Morphine withdrawal; Naltrexone; Striatum

Indexed keywords

INTERLEUKIN 1BETA; MESSENGER RNA; MORPHINE; NALTREXONE; OPIATE RECEPTOR; RANTES; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE EXACERBATION; IN VIVO STUDY; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; NERVE CELL LESION; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WITHDRAWAL SYNDROME;

CCL5; FRONTAL CORTEX; IL-1Β; MICROGLIA; MORPHINE DEPENDENCE; MORPHINE WITHDRAWAL; NALTREXONE; STRIATUM;

ANIMALS; BRAIN; CHEMOKINE CCL5; CYTOKINES; INFLAMMATION; MALE; MICROGLIA; MORPHINE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84885055441     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.08.006     Document Type: Article

References (60)

1. Adler M.W., Rogers T.J. Are chemokines the third major system in the brain?. J. Leukoc Biol. 2005, 78:1204-1209.
2. Avdoshina V., Biggio F., Palchik G., Campbell L.A., Mocchetti I. Morphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120. Glia 2010, 58:1630-1639.
3. Avdoshina V., Becker J., Campbell L.A., Parsadanian M., Mhyre T., Tessarollo L., Mocchetti I. Neurotrophins modulate the expression of chemokine receptors in the brain. J. Neurovirol. 2011, 17:58-62.
4. Bachis A., Cruz M.I., Mocchetti I. M-tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T-tropic gp120 in rat striatum. Eur. J. Neurosci. 2010, 32:570-578.
5. Bakhiet M., Tjernlund A., Mousa A., Gad A., Stromblad S., Kuziel W.A., Seiger A., Andersson J. RANTES promotes growth and survival of human first-trimester forebrain astrocytes. Nat. Cell Biol. 2001, 3:150-157.
6. Bessler H., Sztein M.B., Serrate S.A. Beta-endorphin modulation of IL-1-induced IL-2 production. Immunopharmacology 1990, 19:5-14.
7. Bhat R.S., Bhaskaran M., Mongia A., Hitosugi N., Singhal P.C. Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation. J. Leukoc Biol. 2004, 75:1131-1138.
8. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
9. Bolin L.M., Murray R., Lukacs N.W., Strieter R.M., Kunkel S.L., Schall T.J., Bacon K.B. Primary sensory neurons migrate in response to the chemokine RANTES. J. Neuroimmunol. 1998, 81:49-57.
10. Brown C.M., Mulcahey T.A., Filipek N.C., Wise P.M. Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta. Endocrinology 2010, 151:4916-4925.
11. Bruno V., Copani A., Besong G., Scoto G., Nicoletti F. Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture. Eur. J. Pharmacol. 2000, 399:117-121.
12. Cartier L., Hartley O., Dubois-Dauphin M., Krause K.H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Brain Res. Rev. 2005, 48:16-42.
13. Chen C., Li J., Bot G., Szabo I., Rogers T.J., Liu-Chen L.Y. Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur. J. Pharmacol. 2004, 483:175-186.
14. Chen X., Geller E.B., Rogers T.J., Adler M.W. Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats. Drug Alcohol Depend. 2007, 88:36-41.
15. Cocchi F., DeVico A.L., Garzino-Demo A., Arya S.K., Gallo R.C., Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:1811-1815.
16. Coller J.K., Hutchinson M.R. Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence. Pharmacol. Ther. 2012, 134:219-245.
17. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 1941, 72:74-79.
18. Das S., Kelschenbach J., Charboneau R., Barke R.A., Roy S. Morphine withdrawal stress modulates lipopolysaccharide-induced interleukin 12 p40 (IL-12p40) expression by activating extracellular signal-regulated kinase 1/2, which is further potentiated by glucocorticoids. J. Biol. Chem. 2011, 286:29806-29817.
19. Denes A., Humphreys N., Lane T.E., Grencis R., Rothwell N. Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J. Neurosci. 2010, 30:10086-10095.
20. Desjardins S., Belkai E., Crete D., Cordonnier L., Scherrmann J.M., Noble F., Marie-Claire C. Effects of chronic morphine and morphine withdrawal on gene expression in rat peripheral blood mononuclear cells. Neuropharmacology 2008, 55:1347-1354.
21. El-Hage N., Bruce-Keller A.J., Knapp P.E., Hauser K.F. CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice. J. Neuroimmune Pharmacol. 2008, 3:275-285.
22. El-Hage N., Bruce-Keller A.J., Yakovleva T., Bazov I., Bakalkin G., Knapp P.E., Hauser K.F. Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i) NF-kappaB trafficking and transcription. PLoS One 2008, 3:e4093.
23. Emeterio E.P., Tramullas M., Hurle M.A. Modulation of apoptosis in the mouse brain after morphine treatments and morphine withdrawal. J. Neurosci. Res. 2006, 83:1352-1361.
24. Escola J.M., Kuenzi G., Gaertner H., Foti M., Hartley O. CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi network. J. Biol. Chem. 2010, 285:41772-41780.
25. Gade-Andavolu R., Comings D.E., MacMurray J., Vuthoori R.K., Tourtellotte W.W., Nagra R.M., Cone L.A. RANTES: a genetic risk marker for multiple sclerosis. Mult. Scler. 2004, 10:536-539.
26. Ghirnikar R.S., Lee Y.L., He T.R., Eng L.F. Chemokine expression in rat stab wound brain injury. J. Neurosci. Res. 1996, 46:727-733.
27. Huang D., Han Y., Rani M.R., Glabinski A., Trebst C., Sorensen T., Tani M., Wang J., Chien P., O'Bryan S., Bielecki B., Zhou Z.L., Majumder S., Ransohoff R.M. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol. Rev. 2000, 177:52-67.
28. Hutchinson M.R., Coats B.D., Lewis S.S., Zhang Y., Sprunger D.B., Rezvani N., Baker E.M., Jekich B.M., Wieseler J.L., Somogyi A.A., Martin D., Poole S., Judd C.M., Maier S.F., Watkins L.R. Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav. Immun. 2008, 22:1178-1189.
29. Hutchinson M.R., Lewis S.S., Coats B.D., Skyba D.A., Crysdale N.Y., Berkelhammer D.L., Brzeski A., Northcutt A., Vietz C.M., Judd C.M., Maier S.F., Watkins L.R., Johnson K.W. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain Behav. Immun. 2009, 23:240-250.
30. Hutchinson M.R., Zhang Y., Shridhar M., Evans J.H., Buchanan M.M., Zhao T.X., Slivka P.F., Coats B.D., Rezvani N., Wieseler J., Hughes T.S., Landgraf K.E., Chan S., Fong S., Phipps S., Falke J.J., Leinwand L.A., Maier S.F., Yin H., Rice K.C., Watkins L.R. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav. Immun. 2010, 24:83-95.
31. Hutchinson M.R., Shavit Y., Grace P.M., Rice K.C., Maier S.F., Watkins L.R. Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol. Rev. 2011, 63:772-810.
32. Hutchinson M.R., Northcutt A.L., Hiranita T., Wang X., Lewis S.S., Thomas J., van Steeg K., Kopajtic T.A., Loram L.C., Sfregola C., Galer E., Miles N.E., Bland S.T., Amat J., Rozeske R.R., Maslanik T., Chapman T.R., Strand K.A., Fleshner M., Bachtell R.K., Somogyi A.A., Yin H., Katz J.L., Rice K.C., Maier S.F., Watkins L.R. Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J. Neurosci. 2012, 32:11187-11200.
33. Johnston I.N., Milligan E.D., Wieseler-Frank J., Frank M.G., Zapata V., Campisi J., Langer S., Martin D., Green P., Fleshner M., Leinwand L., Maier S.F., Watkins L.R. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J. Neurosci. 2004, 24:7353-7365.
34. Kaul M., Ma Q., Medders K.E., Desai M.K., Lipton S.A. HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ. 2007, 14:296-305.
35. Kremlev S.G., Roberts R.L., Palmer C. Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. J. Neuroimmunol. 2004, 149:1-9.
36. Lee H.P., Jun Y.C., Choi J.K., Kim J.I., Carp R.I., Kim Y.S. The expression of RANTES and chemokine receptors in the brains of scrapie-infected mice. J. Neuroimmunol. 2005, 158:26-33.
37. Liu L., Coller J.K., Watkins L.R., Somogyi A.A., Hutchinson M.R. Naloxone-precipitated morphine withdrawal behavior and brain IL-1beta expression: comparison of different mouse strains. Brain Behav. Immun. 2011, 25:1223-1232.
38. Paolicelli R.C., Bolasco G., Pagani F., Maggi L., Scianni M., Panzanelli P., Giustetto M., Ferreira T.A., Guiducci E., Dumas L., Ragozzino D., Gross C.T. Synaptic pruning by microglia is necessary for normal brain development. Science 2010, 333:1456-1458.
39. Pribiag, H., Stellwagen, D., 2013. Neuroimmune regulation of homeostatic synaptic plasticity. Neuropharmacology. [EPub ahead of print]. doi:10.1007/s00213-013-3180-2.
40. Ransohoff R.M., Brown M.A. Innate immunity in the central nervous system. J. Clin. Invest. 2012, 122:1164-1171.
41. Rezaie P., Trillo-Pazos G., Everall I.P., Male D.K. Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. Glia 2002, 37:64-75.
42. Roscic-Mrkic B., Fischer M., Leemann C., Manrique A., Gordon C.J., Moore J.P., Proudfoot A.E., Trkola A. RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement. Blood 2003, 102:1169-1177.
43. Rostene W., Kitabgi P., Parsadaniantz S.M. Chemokines: a new class of neuromodulator?. Nat. Rev. Neurosci. 2007, 8:895-903.
44. Roy S., Ninkovic J., Banerjee S., Charboneau R.G., Das S., Dutta R., Kirchner V.A., Koodie L., Ma J., Meng J., Barke R.A. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J. Neuroimmune Pharmacol. 2011, 6:442-465.
45. Sargeant T.J., Miller J.H., Day D.J. Opioidergic regulation of astroglial/neuronal proliferation: where are we now?. J. Neurochem. 2008, 107:883-897.
46. Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Meth. 2012, 9:671-675.
47. Schwarz J.M., Hutchinson M.R., Bilbo S.D. Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression. J. Neurosci. 2011, 31:17835-17847.
48. Schwarz, J.M., Smith, S.H., Bilbo, S.D., 2013. FACS analysis of neuronal-glial interactions in the nucleus accumbens following morphine administration. Psychopharmacology (Berl). [EPub ahead of print]. doi:10.1007/s00213-013-3180-2.
49. Signoret N., Pelchen-Matthews A., Mack M., Proudfoot A.E., Marsh M. Endocytosis and recycling of the HIV coreceptor CCR5. J. Cell Biol. 2000, 151:1281-1294.
50. Szabo I., Chen X.H., Xin L., Adler M.W., Howard O.M., Oppenheim J.J., Rogers T.J. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc. Natl. Acad. Sci. USA 2002, 99:10276-10281.
51. Tonelli L.H., Stiller J., Rujescu D., Giegling I., Schneider B., Maurer K., Schnabel A., Moller H.J., Chen H.H., Postolache T.T. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiat. Scand. 2008, 117:198-206.
52. Tripathy D., Thirumangalakudi L., Grammas P. RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role. Neurobiol. Aging. 2010, 31:8-16.
53. Ubogu E.E., Callahan M.K., Tucky B.H., Ransohoff R.M. CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro. Cell Immunol. 2006, 243:19-29.
54. Wang C.X., Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog. Neurobiol. 2002, 67:161-172.
55. Wang J., Charboneau R., Balasubramanian S., Barke R.A., Loh H.H., Roy S. The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor. J. Leukoc Biol. 2002, 71:782-790.
56. Wang X., Loram L.C., Ramos K., de Jesus A.J., Thomas J., Cheng K., Reddy A., Somogyi A.A., Hutchinson M.R., Watkins L.R., Yin H. Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc. Natl. Acad. Sci. USA 2012, 109:6325-6330.
57. Weed M.R., Steward D.J. Neuropsychopathology in the SIV/macaque model of AIDS. Front Biosci. 2005, 10:710-727.
58. Westmoreland S.V., Alvarez X., deBakker C., Aye P., Wilson M.L., Williams K.C., Lackner A.A. Developmental expression patterns of CCR5 and CXCR4 in the rhesus macaque brain. J. Neuroimmunol. 2002, 122:146-158.
59. Wetzel M.A., Steele A.D., Eisenstein T.K., Adler M.W., Henderson E.E., Rogers T.J. Mu-opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN-gamma-inducible protein-10 expression in human peripheral blood mononuclear cells. J. Immunol. 2000, 165:6519-6524.
60. Zhang Y., Barres B.A. Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr. Opin. Neurobiol. 2010, 20:588-594.